Cargando…

Testosterone Therapy and Mortality Risk

INTRODUCTION: Recent data suggests and increased risk of cardiovascular events and mortality in men on testosterone therapy (TT). To date there are no long term, prospective studies to determine safety. In such cases, retrospective observational studies can be helpful. We examined our patient databa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eisenberg, Michael L., Li, Shufeng, Herder, Danielle, Lamb, Dolores J., Lipshultz, Larry I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312542/ https://www.ncbi.nlm.nih.gov/pubmed/25078049 http://dx.doi.org/10.1038/ijir.2014.29

Ejemplares similares

Risks of testosterone therapy in elderly men
por: Ramasamy, Ranjith, et al.
Publicado: (2014)

Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
por: Pastuszak, Alexander W, et al.
Publicado: (2015)

The importance of understanding baseline reproductive function prior to the administration of exogenous testosterone
por: Kovac, Jason R, et al.
Publicado: (2016)

Varicocele-induced infertility: Newer insights into its pathophysiology
por: Eisenberg, Michael L., et al.
Publicado: (2011)

An approach that someday may boost testosterone biosynthesis in males with late-onset hypogonadism (low testosterone)
por: Lamb, Dolores J.
Publicado: (2019)

The varicocele: diagnostic dilemmas, therapeutic challenges and future perspectives
por: Chiba, Koji, et al.
Publicado: (2016)

Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
por: Dadhich, Pranav, et al.
Publicado: (2017)

Testosterone Replacement Therapy and Prostate Cancer Incidence
por: Eisenberg, Michael Louis
Publicado: (2015)

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
por: Pantalone, Kevin M., et al.
Publicado: (2019)

Endogenous testosterone and mortality risk
por: Meyer, Emily J, et al.
Publicado: (2018)

Men with a complete absence of normal sperm morphology exhibit high rates of success without assisted reproduction
por: Kovac, Jason R, et al.
Publicado: (2017)

Increased Risk of Cancer in Men With Peyronie’s Disease: A Cohort Study Using a Large United States Insurance Claims Database
por: Pastuszak, Alexander W., et al.
Publicado: (2019)

Short-Acting Testosterone: More Physiologic?
por: Westfield, Gerwin, et al.
Publicado: (2020)

The Relationship between Anogenital Distance, Fatherhood, and Fertility in Adult Men
por: Eisenberg, Michael L., et al.
Publicado: (2011)

Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL
por: Madhusoodanan, Vinayak, et al.
Publicado: (2019)

Current trends and therapies in orchialgia management
por: Campbell, Kevin, et al.
Publicado: (2021)

Higher testosterone and testosterone/estradiol ratio in men are associated with better epigenetic estimators of mortality risk
por: Kusters, Cynthia DJ, et al.
Publicado: (2023)

AB19. Testosterone replacement therapy: how safe is it?
por: Goldenberg, Larry
Publicado: (2014)

Risks of testosterone replacement therapy in men
por: Osterberg, E. Charles, et al.
Publicado: (2014)

Testosterone Replacement Therapy and the Risk of Hypoglycemia
por: Yamaguchi, Analía Verónica, et al.
Publicado: (2019)

IVF and ICSI in Male Infertility: Update on Outcomes, Risks, and Costs
por: Karpman, Edward, et al.
Publicado: (2005)

Measurement of endothelial dysfunction via peripheral arterial tonometry predicts vasculogenic erectile dysfunction
por: Kovac, Jason R., et al.
Publicado: (2014)

Testosterone deficiency and cardiovascular mortality
por: Morgentaler, Abraham
Publicado: (2015)

Pharmacology of testosterone replacement therapy preparations
por: Shoskes, Jennifer J., et al.
Publicado: (2016)

Testosterone Replacement Therapy
por: Hellstrom, Wayne J.G.
Publicado: (2004)

Debate about sperm count decline.
por: Orejuela, F, et al.
Publicado: (1998)

Testosterone replacement therapy and the risk of prostate cancer
por: Warburton, Daniel, et al.
Publicado: (2015)

Conclusions about testosterone therapy and cardiovascular risk
por: Anawalt, Bradley D, et al.
Publicado: (2018)

Stem cells, gene therapy, and advanced medical management hold promise in the treatment of male infertility
por: Smith, Ryan P, et al.
Publicado: (2016)

Penile prosthesis in the management of erectile dysfunction following cancer therapy
por: Dadhich, Pranav, et al.
Publicado: (2017)

Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone
por: Salciccia, Stefano, et al.
Publicado: (2020)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

Is Oral Testosterone the New Frontier of Testosterone Replacement Therapy?
por: Ahmad, Syed W, et al.
Publicado: (2022)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

Testosterone Replacement Therapy and Cardiovascular Risk: A Review
por: Corona G, Giovanni, et al.
Publicado: (2015)

Subcutaneous Leydig Stem Cell Autograft: A Promising Strategy to Increase Serum Testosterone
por: Arora, Himanshu, et al.
Publicado: (2018)

Testosterone replacement therapy
por: Shoskes, Daniel A., et al.
Publicado: (2016)

The association between caffeine intake and testosterone: NHANES 2013–2014
por: Glover, Frank E., et al.
Publicado: (2022)

The benefits and risks of testosterone replacement therapy: a review
por: Bassil, Nazem, et al.
Publicado: (2009)

FRI428 VTE And Testosterone Therapy: What Is The Risk?
por: Cheatham, Callie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_edsae4fvhkgb2jt9orfo6aene5